Loading clinical trials...
Loading clinical trials...
Registry Experience at the WAshington Hospital CenteR, DeS - Taxus Liberte vs Xience V
Multicenter, retrospective registry to collect 9-12 month follow-up data to evaluate major adverse cardiac events in patients whom have undergone percutaneous coronary intervention and received either Taxus Liberte or Xience V.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Washington Hospital Center
Washington D.C., District of Columbia, United States
Midwest Cardiovascular Research Foundation
Davenport, Iowa, United States
Iowa Heart Center
West Des Moines, Iowa, United States
Maine Medical Center
Portland, Maine, United States
Washington Adventist Hospital
Takoma Park, Maryland, United States
Genesys Regional Medical Center
Grand Blanc, Michigan, United States
Oklahoma Foundation for Cardiovascular Research
Oklahoma City, Oklahoma, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Grand Strand Regional Medical Center
Myrtle Beach, South Carolina, United States
Heart Clinics Northwest
Spokane, Washington, United States
Start Date
June 1, 2010
Primary Completion Date
September 1, 2010
Completion Date
September 1, 2010
Last Updated
June 2, 2011
1,200
ESTIMATED participants
Lead Sponsor
Medstar Health Research Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT01311323